APRIL 18, 2018 Spotlight Innovation Subsidiary Celtic Biotech Iowa Announces Results from Two Cohorts of Phase I Trial of Crotoxin for the Treatment of Cancer
MARCH 28, 2018 Spotlight Innovation Subsidiary Celtic Biotech Iowa to Present Two Posters at 2018 American Association for Cancer Research (AACR) Annual Meeting
MARCH 13, 2018 Newly Issued U.S. Patent Covers Spotlight Innovation’s Spinal Muscular Atrophy Drug Candidates
JANUARY 11, 2018 Venodol Roll-on, Spotlight Innovation’s New Analgesic Product, Now Available at Amazon.com
SEPTEMBER 27, 2017 Spotlight Innovation Forms Corporate Partnership with University of Iowa Athletics to Promote New Chronic Pain Relief Product “Venodol”
AUGUST 16, 2017 Spotlight Innovation Enters into Sponsored Research Agreement with Indiana University to Develop New Therapies for Spinal Muscular Atrophy
JUNE 30, 2017 Spotlight Innovation Enters into Sponsored Research Agreement to Develop New Therapies for Spinal Muscular Atrophy
Read Spotlight Innovation Press Releases here Visit the Investor Relations page
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.